Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Immunotherapy|May 17, 2023
Plain Language Summary of principles for improving the care of people with eosinophil-associated diseasesDavid J Jackson, Praveen Akuthota, Rebeca Andradas, et al.
Advances in Therapy|October 17, 2022
A Renewed Charter: Key Principles to Improve Patient Care in Severe AsthmaAndrew Menzies-Gow, David J Jackson, Mona Al-Ahmad, et al.
Advances in Therapy|April 30, 2022
Improving Care in Eosinophil-Associated Diseases: A CharterDavid J Jackson, Praveen Akuthota, Rebeca Andradas, et al.
Chest|April 21, 2025
XALOC-1: Clinical Remission Over 2 Years With Benralizumab in Severe Eosinophilic AsthmaGirolamo Pelaia, David J Jackson, Parameswaran Nair, et al.
American Journal of Respiratory and Critical Care Medicine|January 14, 2017
Mucosal Type 2 Innate Lymphoid Cells Are a Key Component of the Allergic Response to AeroallergensJaideep Dhariwal, Aoife Cameron, Maria-Belen Trujillo-Torralbo, et al.
Journal of Asthma and Allergy|July 5, 2022
Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma ExacerbationNicola A Hanania, Jorge F Maspero, David M G Halpin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 9, 2021
Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist CareJohn Busby, Liam G Heaney, Thomas Brown, et al.
Thorax|October 30, 2021
Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trialHugo Farne, Nicholas Glanville, Nicholas Johnson, et al.
Nature Medicine|November 9, 2017
Corrigendum: Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbationMarie Toussaint, David J Jackson, Dawid Swieboda, et al.
The New England Journal of Medicine|February 23, 2024
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Parameswaran Nair, Benjamin Terrier, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Immunotherapy|May 17, 2023
Plain Language Summary of principles for improving the care of people with eosinophil-associated diseasesDavid J Jackson, Praveen Akuthota, Rebeca Andradas, et al.
Advances in Therapy|October 17, 2022
A Renewed Charter: Key Principles to Improve Patient Care in Severe AsthmaAndrew Menzies-Gow, David J Jackson, Mona Al-Ahmad, et al.
Advances in Therapy|April 30, 2022
Improving Care in Eosinophil-Associated Diseases: A CharterDavid J Jackson, Praveen Akuthota, Rebeca Andradas, et al.
Chest|April 21, 2025
XALOC-1: Clinical Remission Over 2 Years With Benralizumab in Severe Eosinophilic AsthmaGirolamo Pelaia, David J Jackson, Parameswaran Nair, et al.
American Journal of Respiratory and Critical Care Medicine|January 14, 2017
Mucosal Type 2 Innate Lymphoid Cells Are a Key Component of the Allergic Response to AeroallergensJaideep Dhariwal, Aoife Cameron, Maria-Belen Trujillo-Torralbo, et al.
Journal of Asthma and Allergy|July 5, 2022
Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma ExacerbationNicola A Hanania, Jorge F Maspero, David M G Halpin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 9, 2021
Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist CareJohn Busby, Liam G Heaney, Thomas Brown, et al.
Thorax|October 30, 2021
Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trialHugo Farne, Nicholas Glanville, Nicholas Johnson, et al.
Nature Medicine|November 9, 2017
Corrigendum: Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbationMarie Toussaint, David J Jackson, Dawid Swieboda, et al.
The New England Journal of Medicine|February 23, 2024
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with PolyangiitisMichael E Wechsler, Parameswaran Nair, Benjamin Terrier, et al.
Pageof 19